In further support of this hypothesis are recent studies that show variants in genes involved in lipid metabolism, including hepatic lipase (LIPC), cholesterylester transfer protein (CETP), and ATP-binding cassette transporter A1 (ABCA1), confer increased risk of AMD (29–32). This evidence concerns the gene CETP and age-related macular degeneration.